common.study.topics.clinical

Effects of a Specific Substance in Smokers

common.study.values.description

Effects of a Specific Substance in Smokers

Although rates of cigarette use are declining, the proportion of nondaily smokers is rising, particularly among young adults. Among young adults, nondaily smoking is associated with negative health consequences and, for some, may lead to the establishment of life-long smoking patterns. The goal of this project is to understand the behavioral, psychological and neurobiological factors that contribute to cigarette use in nondaily smokers to aid the development of tailored evidence-based interventions.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Study Agent

The study agent will be administered via beverages and/or a capsule. The substances used in the study are legal, non-prescription, and are proven safe for human consumption at the doses used. The study agent may be a depressant (such as alcohol), a stimulant (such as caffeine), or an analgesic (such as aspirin).

Drug - Placebo

In the placebo conditions participants will consume beverages and capsules that contain no or very small quantities of the study agent.

participant.views.study.view.additional

participant.views.study.view.scientific-title

An MRI Study of Neural Activity Following Exposure to a Specific Substance in Young Cigarette Smokers

common.study.values.clinical-trial-id

NCT04281979

participant.views.study.view.id

eZ632e